Leadership Team


Thomas Hanly

Managing Director
Thomas has a Bachelor degree in Economics and has a history of commercialising and funding technology projects internationally.

This includes assisting companies to focus on Research and Development within their strategic business process and the raising of capital for product development and commercialisation.

He has helped over 100 companies in Australia to fund and commercialise new innovations.

Prior experience includes working in private banking In Merrill Lynch and consulting to companies in Australia, New Zealand, and the United States.

Denning Chong

Non-Executive Chairman
Denning Chong has been the principal of James Chong Lawyers since 2004. Denning has had the opportunity to assist a cross spectrum of the community - from ASX listed companies and cross border type transactions, to local communities.​

Denning holds directorships with various prominent property development companies, including currently being a director of the Australian subsidiaries of a prominent SGX listed property developer, with a portfolio of over $1 Billion.​

He is also a holder of an AFSL, and a director of a boutique venture capital business focusing on property, financial and medical technology sectors.​

Guan Tay

Non-Executive Director
Holding a PhD from the Centre for Molecular Immunology and Instrumentation at the The University of Western Australia (UWA), Australia for work completed at the Department of Clinical Immunology, Royal Perth Hospital, an MBA and Bachelor of Science (Biotechnology and Biological Sciences Double Major) with Honours (BSc(Hons)) from Murdoch University, Guan is highly respected in the medical and educational sectors.

Currently an Adjunct Associate Professor at the Faculty of Health and Medical Sciences at the University of Western Australia, Dr Tay has held various academic positions over the past 20 years (primarily in an adjunct or visiting capacity) at UWA, as well as Edith Cowan University (ECU). Dr Tay has also managed significant projects at Khalifa University, the premier research-intensive university in Abu Dhabi, the United Arab Emirates.

Thomas Morrell

Chief Technology Officer
Graduating from Staffordshire University with First Class Honours in CGI & Digital Effects, Thomas has worked for a number of well-known companies developing photogrammetry, 360 media and mixed reality applications.

Working on our proprietary Volumetric Rendering Platform since 2017 as our lead developer, Thomas has been instrumental in guiding the technical development of Singular Health's software applications.

Leading our growing team of developers, he has applied his broad knowledge base towards the education sector and creation of mobile application allowing for a highly secure, decentralised patient-driven medical imaging system.

James Hill

Chief Operating Officer
James graduated the University of Western Australia with a Bachelor’s degree in Commerce and has since worked on a number of projects across the fields of Finance, Engineering and Marketing. James provides key and strategic advice on social media marketing and presentation. James has also worked with corporate advisory firms in Perth in business planning and financial modelling.

In his spare time, he heads a team that has produced Australia's most efficient manned electric vehicle. He has served on 5 Not-For-Profit Committee's over the past 6 Years, and is a graduate of the Burgundy Business School (Dijon).

Stephen Alfrich

Business Development Manager​
Stephen graduated Curtin University in Western Australia with both a Bachelor of Applied Science and Graduate Diploma in Business.

He has been in the medical sales industry for 29 years working for companies such as NuVasive Australasia where he was responsible for sales and marketing of Spinal Products in WA and SA​.

He also specialised in the planning and implementation of Staff and Surgeon Training, Curriculum planning and Presentations at Medtronic ANZ. During this time he was also responsible for management of the sales team for spinal and Biological Products.​